Minimal Functional -Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients
Gillard, P., Hilbrands, R., Van de Velde, U., Ling, Z., Lee, D. H., Weets, I., Gorus, F., De Block, C., Kaufman, L., Mathieu, C., Pipeleers, D., Keymeulen, B.Volume:
36
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc13-0128
Date:
November, 2013
File:
PDF, 603 KB
english, 2013